Table 2.
Detailed characteristics of participants in the 3-week high volume Adapted Tango rehabilitative intervention allocated to receive perturbation response testing.
| Participant | Age, y | Sex | Height, m | Weight, kg | PD duration, y | UPDRS III (/108) | H & Y | Dysk (/20) | Medications |
|---|---|---|---|---|---|---|---|---|---|
| PR1 | 68 | M | 1.80 | 80.6 | 5 | 26 | 2 | 1 | C/L, Ent., Rop. |
| PR2 | 79 | M | 1.68 | 68.0 | 3 | 40 | 2 | 0 | C/L, Ama. |
| PR3 | 64 | M | 1.75 | 79.3 | 11 | 25 | 2.5 | 6 | C/L, Ent. |
| PR4 | 81 | M | 1.78 | 83.8 | 3 | 35 | 3 | 0 | C/L, Ent., Ras. |
| PR5 | 74 | M | 1.73 | 76.1 | 5 | 28 | 2 | 0 | C/L |
| PR6 | 73 | F | 1.80 | 62.5 | 4 | 28 | 3 | 0 | C/L, Ras. |
| PR7 | 36 | M | 1.83 | 74.7 | 6 | 29 | 2 | 4 | C/L |
| PR8 | 81 | F | 1.65 | 48.9 | 14 | 31 | 3 | 4 | C/L, Rop. |
| PR9 | 56 | M | 1.85 | 82.9 | 3 | 28 | 2 | 1 | C/L |
Abbreviations: PD, Parkinson’s disease; UPDRS III, Unified Parkinson’s Disease Rating Scale Motor Subscale III; H & Y, modified Hoehn and Yahr stage; Dysk, dyskinesia score, C/L, carbidopa/levodopa; Ent., entacapone; Rop., ropinirole; Ama., amantadine; Ras., Rasagiline.